#Title21
[作品情報/配信中.]-Thank you for your time.

#小説 [弛まぬ言霊] -挿画&グッズカタログ
<デザイン画集:Comics Style Version.>
<著者/挿画作成> 凛々風 猛-リリカゼタケル
amzn.asia/d/fxD6D5U

挿画title21. 未来地図 │ グッズ商品追加
#アップティーマーケット
market.up-t.jp/6955d75a60d64
January 21, 2026 at 7:39 AM
📢 Title21 Health Solutions has acquired MyCellHub — expanding our digital capabilities in cell & gene therapy and strengthening GMP manufacturing, quality, and compliance.

Read the full announcement 👉 www.einpresswire.com/article/8805...

#CGT #CellAndGeneTherapy #AdvancedTherapies #LifeSciences
January 6, 2026 at 1:22 PM
Title21 has joined the Blood and Cells Advocacy Roster (BCAR), supporting the advancement of blood and cell therapies through regulatory and compliance technology that helps blood centers streamline operations and expand patient access.

Read the full press release → pharmatimes.com/news/title21...
December 16, 2025 at 8:55 PM
Happy Thanksgiving from Title21 Health Solutions!

This holiday season, we are reflecting on our profound gratitude for the biotherapy community and the daily strides being made to improve patient outcomes. Wishing you a wonderful and restorative day!
November 26, 2025 at 4:33 PM
How do we scale autologous therapies without losing speed or safety?
Heather Purvis, Director of Clinical Operations at Title21, explores this question in the new BioProcess International eBook on supply chain scalability.
Download here → www.bioprocessintl.com/cell-therapi...
November 12, 2025 at 6:00 PM
See Title21 Health Solutions at AABB 2025!

Discover how we're Accelerating Therapies from Collection to Care at Booth #1120.

🗓️ Schedule your meeting with the team: share.hsforms.com/2XOvGt1d1Rqa...

#AABB2025 #CellandGeneTherapy #StandardofCare #Manufacturing #Quality #Analytics
October 21, 2025 at 6:12 PM
Planning your agenda for the #AABB2025 Annual Meeting? Make sure to add Title21 Health Solutions to your list!

📍 Find us at Booth #1120

Skip the line and guarantee time with our team by scheduling a meeting today.
🗓️ Book a Meeting: share.hsforms.com/2XOvGt1d1Rqa...
October 15, 2025 at 5:26 PM
▶︎小説 [弛まぬ言霊] 挿画&グッズカタログ
<#デザイン画集 #ComicsStyleVersion.>
<著者/挿画作成> 凛々風 猛-リリカゼタケル
日本語版: amzn.asia/d/fxD6D5U
_____________________
<#グッズ シリーズ>
▶︎SUZURI: suzuri.jp/ririkazetakeru
▶︎UPT: up-t.jp/creator/66b9c067ae64e

▶︎ 挿画title21. 未来地図
October 12, 2025 at 9:39 PM
刺すように燃えるような眼差しは [+挿画51作品版]
<著者/ #挿画 作成> 凛々風 猛 -リリカゼタケル
#小説 日本語版: amzn.asia/d/8oNk92Q
英語版: amzn.asia/d/gDGn5nK
_____________________
<#グッズ -Version2.>
▶︎SUZURI: suzuri.jp/ririkazetakeru
▶︎UPT: up-t.jp/creator/66b9c067ae64e

挿画title21. #浪漫の翼を広げて
August 30, 2025 at 11:27 PM
We brought the whole Title21 team, including our remote crew, to Phoenix for an All Employee meeting that was an absolute blast! Think collaboration, learning, and a delicious Italian cooking masterclass.

#TeamBuilding #TeamWork #CompanyCulture
August 26, 2025 at 6:42 PM
In Delaware, we just call all these higher-speed devices (without any confusion) "mopeds." delcode.delaware.gov/title21/c001...
August 16, 2025 at 4:25 PM
State law: "A local authority or state agency which has jurisdiction over a bicycle or multi-use path may prohibit the operation of a [electric] bicycle if... the restriction is necessary for safety reasons..." delcode.delaware.gov/title21/c041...
Delaware Code Online
delcode.delaware.gov
July 30, 2025 at 10:18 PM
Embracing a digital platform isn't just an upgrade; it's essential for scaling your work.

Read more about Title21's role➡️https://www.title21.com/streamlining-success-how-digital-solutions-are-revolutionizing-cgt-equipment-management/

#CGT #Pharma #BioTech #Innovation
July 10, 2025 at 8:14 PM
Title21's Jonathan Wofford joined Discover Pharma to discuss the future of CGT manufacturing, focusing on the crucial role of data and digital innovation.

See what Jonathan and other industry leaders had to say!

➡️ discover-pharma.com/unlocking-co...

#CGT #Pharma #Collaboration #Title21
July 8, 2025 at 7:10 PM
Today is World Sickle Cell Day! Title21 stands in solidarity with the millions globally living with Sickle Cell Disease (SCD), a genetic blood disorder that profoundly impacts lives. Together, we can push for a future where SCD is no longer a life-limiting diagnosis.
#WorldSickleCellDay
June 19, 2025 at 6:43 PM
June is Cancer Survivors Month, a time to celebrate the victories won by patients every single day. Their stories are at the heart of everything we do at Title21. Today we celebrate every survivor and the hope they represent!

#CancerSurvivorsMonth
June 12, 2025 at 5:25 PM
_____________________
▶︎弛まぬ言霊[+挿画50作品版]
<#小説 #作詞 #挿画作成>
凛々風猛 -ririkazetakeru
日本語版: amzn.asia/d/3czgKs8
英語版: amzn.asia/d/bpIME7s
_____________________
<#グッズシリーズ>
-designs remastered-
#SUZURI suzuri.jp/ririkazetakeru
#UP-T up-t.jp/creator/66b9c067ae64e

-挿画title21. 未来地図
May 11, 2025 at 1:37 AM
Big news! Title21 just formed its first CGT Advisory Committee
Welcome, Dr. Stella Vnook, Dr. Elena Maryamchik, Jeff Liter, Robert Richards, and Caitlin Cahill—the minds helping shape our cell & gene therapy platform.

Details: www.title21.com/title21-heal...

#CellTherapy#GeneTherapy#LifeSciences
May 6, 2025 at 6:01 PM
Heading to #ISCT2025? Let’s talk!

Title21’s integrated software helps #CellAndGeneTherapy teams optimize workflows, improve compliance, and scale treatments faster.

Book a meeting for a custom demo in NOLA! 👉https://share.hsforms.com/2ln_rq9x-RfuwKGnKhEu93A126sl
April 28, 2025 at 5:30 PM
This week, Title21 proudly celebrates Medical Laboratory Professionals Week! To all the dedicated medical laboratory
professionals - thank you for your crucial role in patient well-being. Happy Medical Laboratory Professionals Week!

#MedLabProsWeek #LabProfessionals #HealthcareHeroes
April 21, 2025 at 5:59 PM
Cell and gene therapies (CGTs) are transforming patient care, but are clinical centers ready? Heather Purvis of Title21 shares key insights on overcoming challenges to adopt these life-saving therapies.

🔗 View insights here: www.title21.com/preparing-cl...

#CGT #HealthcareInnovation #GeneTherapy
Preparing Clinical Centers for the Growing Demand of Cell and Gene Therapies: Insights from IBTV Panel Discussion - Title21 Health Solutions
As cell and gene therapies (CGTs) progress from the laboratory to patient care, clinical centers face unique challenges in adapting to these groundbreaking treatments.
www.title21.com
April 16, 2025 at 7:45 PM
“Skilled clinical staff are more in demand than ever—and cuts to NIH funding are driving costs even higher,” says Heather Purvis of Title21 in Clinical Trials Arena.

📰 Read the article here: www.clinicaltrialsarena.com/features/how...

#Biotech #CellAndGeneTherapy #NIHFunding #LifeSciences
How can pharma manage rising trial costs?
With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage expenses.
www.clinicaltrialsarena.com
April 14, 2025 at 5:24 PM
_____________________
▶︎弛まぬ言霊[+挿画50作品版]
<#小説 #作詞 #挿画作成>
凛々風猛 -ririkazetakeru
日本語版: amzn.asia/d/3czgKs8
英語版: amzn.asia/d/bpIME7s
_____________________
<#グッズ シリーズ>
▶︎オリジナルアイテム類 #SUZURI
suzuri.jp/ririkazetakeru
▶︎オリジナルTシャツ類 #UPT
up-t.jp/creator/66b9c067ae64e

-挿画title21. 未来地図
April 13, 2025 at 2:33 AM
We’re excited to welcome Jonathan Wofford as our first Chief Commercial Officer (CCO)! With 20+ years in cell therapy & stem cell transplant tech, he’s set to drive innovation & expand our impact in biotherapy.

Learn more: www.title21.com/title21-heal...

#LifeSciences #CellTherapy #GeneTherapy
April 8, 2025 at 4:39 PM